Aclidinium Bromide

• CAT Number: A000456
• CAS Number: 320345-99-1
• Molecular Formula: C26H30BrNO4S2
• Molecular Weight: 564.6
• Purity: ≥95%
• Synonyms: 320345-99-1; Genuair; Aclidinium (Bromide); UNII-UQW7UF9N91; Tudorza Pressair
• Target: Neuronal Signaling
• Solubility: Soluble in DMSO > 10 mM
• Storage: -20°C
• InChI: 1S/C26H30NO4S2.BrH/c28-25(26(29,23-9-4-17-32-23)24-10-5-18-33-24)31-22-19-27(14-11-20(22)12-15-27)13-6-16-30-21-7-2-1-3-8-21;/h1-5,7-10,17-18,20,22,29H,6,11-16,19H2;1H/q+1;/p-1/t20?,22-,27?;/m0./s1
• InChIKey: XLAKJQPTOJHYDR-QTQXQZBYSA-M
• SMILES: C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5.[Br-]

Aclidinium Bromide is a long-acting anticholinergic bronchodilator used primarily in the management of chronic obstructive pulmonary disease (COPD). By inhibiting muscarinic receptors in the smooth muscle of the airways, it reduces bronchoconstriction, improving airflow and respiratory function in patients. Aclidinium Bromide is administered via inhalation and has a rapid onset of action, with prolonged therapeutic effects that provide sustained relief from COPD symptoms. It is designed for twice-daily dosing and exhibits a favorable safety profile with fewer systemic side effects. Its selective action on the lungs makes it a key treatment option in respiratory care.